Heparine Leo

Heparine Leo is a prescription intravenous medication that contains the active ingredient heparin sodium. The specific strength and dosage form are not disclosed, and it is marketed in the European Union. As an anticoagulant, Heparine Leo works by enhancing antithrombin III activity to inhibit clotting factors, making it suitable for managing various thrombotic conditions under medical supervision.

Heparine Leo is indicated for several antithrombotic purposes in clinical practice.

- Prevention and treatment of thromboembolic disorders such as pulmonary embolism and arterial thrombosis. - Management of acute coronary syndrome, including unstable angina and myocardial infarction. - Prophylaxis of deep vein thrombosis (DVT) in surgical or immobilized patients. - Use during cardiac surgery or interventional procedures requiring anticoagulation. - Adjunct therapy in patients with high risk of clot formation.

Heparine Leo may cause a range of side effects, varying in frequency and severity.

Common: - Minor bleeding at injection sites. - Bruising or hematoma formation. - Nausea or mild gastrointestinal discomfort. - Transient elevation of liver enzymes. - Mild thrombocytopenia (low platelet count).

Serious: - Major hemorrhage, including internal bleeding. - Heparin-induced thrombocytopenia (HIT) with paradoxical clotting. - Severe allergic reactions such as anaphylaxis. - Spontaneous spinal or epidural hematoma. - Acute renal impairment associated with bleeding complications.

Before initiating Heparine Leo, several safety considerations should be reviewed.

- Assess patient’s bleeding risk, including history of ulcers, recent surgery, or trauma. - Monitor coagulation parameters (e.g., activated partial thromboplastin time) regularly. - Use with caution in patients with renal or hepatic impairment. - Evaluate pregnancy status; benefits must outweigh potential risks. - Discontinue or adjust dose prior to invasive procedures. - Educate patients on signs of abnormal bleeding and when to seek medical attention.

Heparine Leo can interact with various medications, influencing its anticoagulant effect.

Avoid: - Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants). - Thrombolytic agents such as alteplase or streptokinase. - Antiplatelet drugs (e.g., clopidogrel, ticagrelor) in high‑dose regimens.

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) and aspirin. - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents. - ACE inhibitors and angiotensin receptor blockers that may increase bleeding risk. - Certain antibiotics (e.g., quinolones) that can affect platelet function.